46 Woodstock Road,
Oxford, OX2 6HT
NOV 19, 2025
Founder and former CEO to apply expertise in AI and next-generation computing to co-found and scale a new venture within Oxford’s science ecosystem
Oxford, UK – October 2025 – Oxford Science Enterprises (OSE) has appointed Venetia Jennings as an Entrepreneur-in-Residence (EIR) within its Deep Tech team, focused on opportunities in AI and next-generation computing.
Venetia joins OSE with over a decade of experience spanning technology entrepreneurship and consulting. Most recently, she co-founded xcharta, a computer vision start-up focused on the precision extraction of numerical data from images. As CEO and CTO, she was responsible for developing the core technology and building the business.
Previously, Venetia was a Senior Manager at Bain & Company and an Associate at the prestigious law firm Slaughter and May. She holds an MSc in Computing from Imperial College London, an MA in Classics from Oxford University, and a Postgraduate Diploma in Law from BPP Law School.
Sam Harman, Partner and Head of Deep Tech at OSE, said: “We are delighted to welcome Venetia to the Deep Tech team. Her rare blend of expertise, as both a technical co-founder and a strategic leader with experience at world-class firms, is exactly the profile we’re looking for in our EIR programme. She will play an invaluable role in working with us to identify and launch the next foundational company in the rapidly evolving space of AI and next-generation computing.”
Venetia Jennings, Entrepreneur-in-Residence at OSE, commented: “Returning to Oxford in this capacity is incredibly exciting. The ecosystem is a true global frontier for deep science and research that will define the next generation of innovation. I look forward to partnering with academics and the investment team to identify a breakthrough idea and build a company with the potential to lead a new market category.”
OSE attracts experienced founders and proven leaders to Oxford through its Entrepreneurs-in-Residence programme, partnering with them to identify breakthrough ideas and ultimately found new ventures. The programme provides direct access to Oxford’s world-class science, capital, and a clear path to spinout. It is a core part of OSE’s mission to find, fund and build world-changing companies, and has already led to the creation of pioneering spinouts including Neu Health, Amber Therapeutics, and Salience Labs.
OSE’s Deep Tech team is focused on technology grounded in engineering, physics and data, with the potential to reshape entire industries and solve global challenges. The team supports the creation of new foundational technologies, products, standards and categories across areas as pressing and broad-ranging as clean hydrogen, quantum computing, advanced material design, neuromorphic chips, software & AI, and cybersecurity.
About Oxford Science Enterprises
Oxford Science Enterprises (OSE) is an independent, billion-pound investment company that finds, funds and builds transformational science and technology companies emerging from Oxford’s world-leading research. Our portfolio of companies is focused across three high-impact sectors – Deep Tech, Life Sciences, and HealthTech – with the ambition of tackling some of the world’s greatest challenges. To date, OSE has collaborated with over 300 international investors, collectively investing over £3 billion in more than 100 groundbreaking companies.